Abdu Adem Yesufe

Dr. Abdu Adem Yesufe

Oncology, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ādīs Ābeba, Ethiopia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
MDMekonnen Dessalegn
Mekonnen Dessalegn
MFMengistu Fantahun
Mengistu Fantahun
Abdu Adem YesufeAbdu Adem Yesufe
Abdu Adem Yesufe
MHMintewab Hussein
Mintewab Hussein
ATAster Tsegaye
Aster Tsegaye
Background: Globally the incidence of cancer is about 19.3 million new cases per year. Chemotherapy is among the standard treatments for cancer but neutropenia and febrile neutropenia are the most common side effects. Objective: To assess the incidences of chemotherapy-induced neutropenia, febrile-neutropenia and associated factors in solid cancer patients attending Oncology unit of St. Paul Hospital Millennium Medical College in Addis Ababa, Ethiopia. Methods: In this institution-based longitudinal study conducted from February to September, 2020 at one of the largest teaching and referral hospitals of Ethiopia, 101 patients who were diagnosed with any type of solid cancer were recruited using convenience sampling method. Patients were followed-up until they completed five cycles of chemotherapy. Data were analyzed using SPSS version 23 software. Paired sample t-test was used to compare the pre- and post-treatment results. Chi-squared test was employed to determine associated factors of neutropenia, and p-values less than 0.05 were taken as statistically significant. Results: Of the total 101 participants, 98 were eligible per inclusion criteria and 6 (6.1%) of them died during the study period. The age of the participants ranged from 16– 84 years with a mean age of 45. Of them, 48 (49.0%) were in the age group of 16– 44 years, 73 (74.5%) were female, 66 (67.3%) were married, and 42.9% attained primary education. Among 92 patients, the incidence of neutropenia was 65 (70.7%) and the incidence of febrile neutropenia was 46 (50.0%). Adriamycin + cyclophosphamide and Adriamycin + cyclophosphamide + paclitaxel were the most commonly used anti-cancer treatments in this study. None of the tested factors were associated with chemo-induced neutropenia. Conclusion: More than two thirds of the patients had chemotherapy associated neutropenia while half of the patients had febrile neutropenia; close monitoring of such patients is warranted.

1 December 2018 in Journal of Global Oncology
Verified
Journal Article
Open access
Abdu Adem YesufeAbdu Adem Yesufe
Abdu Adem Yesufe
MAMathewos Assefa
Mathewos Assefa
ABAbebe Bekele
Abebe Bekele
WEWondwossen Ergete
Wondwossen Ergete
AAAbreha Aynalem
Abreha Aynalem
AJAhmedin Jemal
Ahmedin Jemal
Purpose: Although information from pathology reports is essential to the care of individuals with cancer and to population-level cancer control, no systematic evidence exists regarding the adequacy of breast pathology reporting in Ethiopia. This study audited pathology reports of mastectomy specimens from patients evaluated at the Tikur Anbessa Specialized Hospital Oncology Center in Addis Ababa, Ethiopia.Methods: Mastectomy pathology reports from February 2014 through January 2016 were assessed for gross and microscopic information considered by the Breast Cancer Initiative 2.5 (BCI 2.5; formerly the Breast Health Global Initiative) guideline to be necessary for care of patients with breast cancer stratified according to basic, limited, and enhanced resource settings.Results: Fewer than two thirds (61.6%) of the 417 reports we reviewed included all four of the BCI 2.5 basic pathology data elements we could evaluate with available data (tumor category, lymph node category, histologic type, and histologic grade). Only 1.0% of reports included all three pathology data elements recommended for limited resource settings (estrogen receptor status, margin status, and lymphovascular invasion). Several elements were significantly more likely to be noted in reports from nonpublic hospitals than from public hospitals. Although only three of 417 reports included checklists or templates, all three of these reports included all of the basic pathology information, and they all included at least two of the three limited pathology elements not already on the basic list.Conclusion: More than one third (38.4%) of mastectomy pathology reports did not meet BCI 2.5 standards for basic resource settings. Quality measurement and improvement programs and capacity-building interventions by national pathology and oncology organizations, collaboration with medical and public health organizations in neighboring countries, adoption of synoptic reporting templates, use of electronic pathology reporting, and histotechnology and histopathology training collaborations with laboratories in high-resource regions are recommended.

28 December 2022 in Cancers
Verified
Journal Article
Open access
PDF file
GAGetahun Befirdu Abza
Getahun Befirdu Abza
JAJemal Hussien Ahmed
Jemal Hussien Ahmed
Abdu Adem YesufeAbdu Adem Yesufe
Abdu Adem Yesufe
EWEdom Woldetsadik
Edom Woldetsadik
MMMengistu Minaye
Mengistu Minaye
PAPieter Annaert
Pieter Annaert
(1) Background: Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, killing over 700,000 people each year. Despite the rising incidence and mortality rates of HCC in Ethiopia, only few single-centered studies have been conducted; therefore, we aimed to explore the clinicopathological characteristics and survival of patients with HCC in multicenter settings. (2) Methods: We conducted a retrospective analysis of 369 patients with confirmed HCC diagnosed between 2016 and 2021. The survival of patients weas determined using the Kaplan–Meier method, and hazard ratios of the prognostic factors were estimated in Cox proportional hazard models. (3) Results: Majority patients were male (67%) and had a mean age of 52.0 ± 15.6 years. The majority of patients (87%) had a large tumor size (>5 cm) at diagnosis and presented with an advanced-stage condition. Cirrhosis (58%) and viral hepatitis (46.5%) were the main risk factors associated with HCC. The median overall survival was 141 days (95% CI: 117–165). Patients who took antivirals for HBV had a higher survival benefit compared to the untreated group (469 vs. 104 days; p < 0.001). The risk of death was 12 times higher in patients with Barcelona Clinic Liver Cancer-D (BCLC-D) terminal stage HCC compared to patients with an early stage (BCLC-A) HCC. The stage of HCC and treatment against HBV are the most significant survival predictors. (4) Conclusions: The overall survival of HCC patients in Ethiopia is poor. Cirrhosis and viral hepatitis are the primary risk factors linked with HCC. Patients who received antiviral therapy for HBV had a better survival outcome.

17 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
BSBirtukan Shewarega
Birtukan Shewarega
SGSefonias Getachew
Sefonias Getachew
NANigussie Assefa
Nigussie Assefa
Abdu Adem YesufeAbdu Adem Yesufe
Abdu Adem Yesufe
JTJosephin Trabizsch
Josephin Trabizsch
MGMuluken Gizaw
Muluken Gizaw
Breast and cervical cancers are the most common causes of cancer incidence and mortality in women in Africa. Women with breast and cervical cancers in Sub-Saharan Africa (SSA) are frequently diagnosed at advanced stages. Delays in health seeking, diagnosis and treatment are contributing factors to high mortality in Ethiopia. This study aimed to assess predictors of advanced stage presentation among breast and cervical cancer patients attending public hospitals in Addis Ababa, Ethiopia. A cross-sectional study was conducted with a total of 418 patients at Tikur Anbessa specialized hospital and Saint Pauls’ Hospital Millennium Medical College from October to November 2021. Stages III and IV were considered advanced stages. Data were collected by reviewing medical records and in face-to-face interviews with a structured questionnaire. Bivariate and multivariate analyses were performed to examine the association between independent and outcome variables. A total of 269 patients with breast cancer and 149 patients with cervical cancer were included in the study, and the mean age was 44 years (SD = 10.9 years) and 50 years (SD = 11.2) years, respectively. About 66.9% of breast cancers and 71.1% of cervical cancers were diagnosed at an advanced disease stage. Rural residence (AOR = 2.041, 95% CI: 1.108–3.758), indirect referral (AOR = 3.8, 95% CI: 1.485–9.946), financial difficulty (AOR = 10, 95% CI: 1.859–56.495) and no prior advise/awareness about screening (AOR = 4.029 95%CI: 1.658–10.102) were independent predictors of advanced-stage presentation. This study revealed a high prevalence of advanced-stage breast and cervical cancer diagnosis in Ethiopia, similar to data collected 10 years ago, despite the introduction of a cancer control plan in 2015. For better implementation, interventions should aim to improve referral pathways, adapt screening and early detection services and increase cancer awareness at the community level in a culturally accepted way.

25 March 2026 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
BGBlen Alemu Gebremedhin
Blen Alemu Gebremedhin
GTGloria Thupayagale-Tshweneagae
Gloria Thupayagale-Tshweneagae
Abdu Adem YesufeAbdu Adem Yesufe
Abdu Adem Yesufe
Purpose: The lack of evidence-based knowledge about women’s experiences after mastectomy has serious implications for mastectomy-supportive care in the Ethiopian health system. Thus, the purpose of this study was to explore the lived experiences of women who had a mastectomy without reconstruction and consequently develop guidelines for healthcare providers to enhance supportive care. Methods: This qualitative study is grounded in feminist values and Heidegger’s philosophy of existential phenomenology. It was conducted at St. Paul’s Hospital Millennium Medical College, one of the largest hospitals in the country, which provides cancer care. Purposive sampling was used until saturation was reached. Thus, twenty women with an average survival time of 2 years who had undergone mastectomy without reconstruction were interviewed in-depth about their mastectomy experience. The data were analysed using interpretive phenomenological analysis (IPA) employing the ATLAS.ti 9 version qualitative data analysis software. Results: Five themes emerged from the analysis of the interview data: body image and appearance-related concerns, psychological effects and social relationships, concerns about sexual function, healthcare-related experiences, and coping strategies. The findings of this study showed that women encounter ongoing challenges following breast cancer diagnosis and mastectomy that healthcare workers do not adequately address. Conclusion: Consequently, the findings resulted in the development of guidelines to promote quality mastectomy care tailored to the needs of women who choose or are unable to undergo reconstruction. Policymakers, health care administrators, and professionals can use these guidelines as a resource for initiatives to improve supportive care for women who have had a mastectomy without reconstruction.

20 May 2026 in The Oncologist
Verified
Journal Article
Open access
EHEva S M Hermann
Eva S M Hermann
ESEdom Seife
Edom Seife
PSPablo S C Santos
Pablo S C Santos
EKEric S Kroeber
Eric S Kroeber
SASolomon Asmare
Solomon Asmare
EKEva Johanna Kantelhardt
Eva Johanna Kantelhardt
Background: Chemotherapy is an essential component of comprehensive cancer care and timely access can improve survival outcomes. The objective of this study was to assess the time to chemotherapy initiation and patient-reported barriers to cancer care among patients from Addis Ababa, Ethiopia. Methods: We conducted a retrospective study using a randomly selected sample of 350 patients with common cancers (breast [ICD-10: C50], cervical [C53], colorectal [C18-20], oesophageal [C15], gastric [C16] and ovarian [C56]) registered at the population-based Addis Ababa City Cancer Registry (AACCR) in 2021. Patients or their relatives were followed-up via questionnaire-based telephone interview and treatment data were extracted from their medical records. The time from pathological diagnosis to initiation of chemotherapy (time to treatment) was calculated. Regression analyses were conducted to identify predictors of chemotherapy initiation and treatment delays. Results: Most patients (71.7%) received chemotherapy and the median time to treatment was 63 days (IQR 36.5 to 128 days). Patients reported considerable barriers to treatment regarding fear, cost and waiting times. Having health insurance (OR 2.70; 95% CI 1.33 to 5.50) and trust in healthcare professionals (OR 1.76; 95% CI 1.16 to 2.68) were associated with higher odds of receiving chemotherapy. Patients with cervical (OR 0.07; 95% CI 0.03 to 0.18), gastric (OR 0.21; 95% CI 0.05 to 0.86) or oesophageal cancer (OR 0.10; 95% CI 0.02 to 0.53) were less likely to initiate chemotherapy compared to breast cancer patients. Longer time to treatment was not associated with any of the assessed characteristics or perceived barriers. Conclusion: Over half of the cancer patients from Addis Ababa wait more than two months to initiate chemotherapy after a pathological diagnosis. Expanding oncology services and health insurance coverage could enhance access to treatment. Health professionals should promote patient trust by appropriately addressing their psychosocial needs, including cancer-related fear, to improve the uptake of treatment and thus clinical outcomes. Implications for practice: Improving access to timely chemotherapy requires coordinated action across multiple levels. Strengthening health system capacity and care coordination is essential to reduce delays, while improving provider-patient communication and integrating psychosocial support can address fear and enhance treatment uptake and adherence. Expanding health insurance coverage may reduce financial barriers but must be accompanied by increased service availability to be effective.